Article
PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes.
International journal of rheumatic diseases - 1 Oct 2017
Kwon Eun-Jeong, Park Eun-Jung, Choi Sungwook, Kim Sang-Rim, Cho Moonjae, Kim Jinseok
Abstract excerpt
AIM: Peroxisome proliferator-activated receptor gamma (PPARγ) agonists have anti-inflammatory properties that reduce inflammatory cytokine production in rheumatoid arthritis (RA). Cysteine-rich angiogenic inducer 61 (Cyr61) is associated with diseases related to chronic inflammation. The aim of this study was to investigate the mechanisms underlying the effects of PPARγ agonists on tumor necrosis factor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
